Share this article and save a life!
The largest AI breast cancer screening trial in U.S. history just launched, and the early data is mind-blowing. 🔍
The $16 million PRISM Trial (Pragmatic Randomized Trial of AI for Screening Mammography) is evaluating how AI transforms breast cancer detection across hundreds of thousands of mammograms.
Here’s why every healthcare leader should be paying attention:
• Real-world data shows the Transpara AI system detects 29% more breast cancers compared to standard screening
• Radiologist workload is reduced by 44% without increasing recall rates
• Sensitivity improved from 81.7% to 87.2% in clinical studies
• The system flags 76% of mammograms initially read as normal but later linked to interval cancers
• Low-risk exams show a 99.97% negative predictive value, reliably ruling out cancer
What makes this trial different is its scale and design. While previous studies were conducted in controlled settings, PRISM is happening in diverse real-world clinical environments across California, Florida, Massachusetts, Washington, and Wisconsin.
The integration is surprisingly straightforward. The AI analyzes both 2D and 3D mammography images, highlights suspicious areas, and assigns a risk score from 1-10. All final interpretations still come from radiologists, with AI serving as an intelligent assistant.
But the implications extend far beyond workflow improvement. This technology directly addresses three critical challenges:
1. The radiologist shortage crisis that’s bottlenecking screening programs
2. The persistent problem of missed cancers that appear on retrospective review
3. The psychological burden on patients from unnecessary recalls
For imaging center leaders and healthcare executives, this represents a rare technological advancement that simultaneously improves clinical outcomes, operational efficiency, and patient experience.
The PRISM Trial results will likely determine how quickly this technology becomes the standard of care, influencing both clinical guidelines and insurance coverage policies.
Questions for my network: Has your organization implemented any AI tools in your imaging workflow? If so, what results have you seen? If not, what’s holding you back?
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
